Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa.

MLA

Kantele, Anu, et al. “Safety and Immunogenicity of ETVAX®, an Oral Inactivated Vaccine against Enterotoxigenic Escherichia Coli Diarrhoea: A Double-Blinded, Randomized, Placebo-Controlled Trial amongst Finnish Travellers to Benin, West Africa.” Journal of Travel Medicine, vol. 30, no. 7, Nov. 2023. EBSCOhost, https://doi.org/10.1093/jtm/taad045.

APA

Kantele, A., Riekkinen, M., Jokiranta, T. S., Pakkanen, S. H., Pietilä, J.-P., Patjas, A., Eriksson, M., Khawaja, T., Klemets, P., Marttinen, K., Siikamäki, H., Lundgren, A., Holmgren, J., Lissmats, A., Carlin, N., & Svennerholm, A.-M. (2023). Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa. Journal of Travel Medicine, 30(7). https://doi.org/10.1093/jtm/taad045

Chicago

Kantele, Anu, Marianna Riekkinen, T Sakari Jokiranta, Sari H Pakkanen, Jukka-Pekka Pietilä, Anu Patjas, Mari Eriksson, et al. 2023. “Safety and Immunogenicity of ETVAX®, an Oral Inactivated Vaccine against Enterotoxigenic Escherichia Coli Diarrhoea: A Double-Blinded, Randomized, Placebo-Controlled Trial amongst Finnish Travellers to Benin, West Africa.” Journal of Travel Medicine 30 (7). doi:10.1093/jtm/taad045.